Tumor cells use a variety of different pathways to achieve this goal including overexpression of certain cytokines (IL-4, IL-10, TGFB), catabolic enzymes such as indoleamine 2,3 dioxygenase, and also by upregulation of surface PD-L1 expression. This evidence concerns the gene TGFB1 and neoplasm.